CL&M Assists Trinity Biotech plc with a Public Offering

We advised our client Trinity Biotech plc (NASDAQ: TAB), an Irish diagnostic company, in connection with a public offering of 2,675,000 American Depositary Shares for $23 million, which closed on April 11, 2006. Roth Capital Partners and J&E Davy acted as placement agents for investors located in the United States, United Kingdom, Ireland, France and Switzerland. The CL&M team lead by Alan J. Bernstein, included Peter Flägel, Rick Horne and Pamela Shelinsky.

Latest News

See all news items

© Copyright 2020 Carter Ledyard & Milburn LLP